The regulation of IGF-1 gene transcription and splicing during development and aging

Frontiers in Endocrinology

Volumn 4, Issue MAR, 2013, Pages

  Oberbauer, A M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 UTR; IGF 1; Promoter; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; COLLAGEN; EC PEPTIDE; ESTROGEN RECEPTOR ALPHA; GLUTAMATE RECEPTOR; GROWTH HORMONE; HEPATOCYTE NUCLEAR FACTOR; JANUS KINASE; MICRORNA 1; MYOD1 PROTEIN; PEPTIDES AND PROTEINS; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAT5 PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AGING; BINDING AFFINITY; CHROMATIN IMMUNOPRECIPITATION; DEVELOPMENT; DOWN REGULATION; EPIGENETICS; FOOD DEPRIVATION; GENE EXPRESSION; GENE STRUCTURE; HUMAN; MUTATION; NONHUMAN; PROMOTER REGION; REVIEW; RNA SPLICING; RNA TRANSLATION; TRANSCRIPTION REGULATION;

EID: 84884200620     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00039     Document Type: Review

References (104)

1. Adamo, M., Lowe, W. L. Jr., Leroith, D., and Roberts, C. T. Jr. (1989). Insulin-like growth factor I messenger ribonucleic acids with alternative 5β-untranslated regions are differentially expressed during development of the rat. Endocrinology 124, 2737-2744.
2. Adamo, M. L., Ben-Hur, H., Leroith, D., and Roberts, C. T. (1991a). Transcription initiation in the two leader exons of the rat IGF-I gene occurs from disperse versus localized sites. Biochem. Biophys. Res. Commun. 176, 887-893.
3. Adamo, M. L., Ben-Hur, H., Roberts, C. T., and Leroith, D. (1991b). Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol. Endocrinol. 5, 1677-1686.
4. Aperghis, M., Velloso, C. P., Hameed, M., Brothwood, T., Bradley, L., Bouloux, P. M. G., et al. (2009). Serum IGF-I levels and IGF-I gene splicing in muscle of healthy young males receiving rhGH. Growth Horm. IGF Res. 19, 61-67.
5. Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis, A. (1993). Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73-82.
6. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
7. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
8. Beresewicz, M., Majewska, M., Makarewicz, D., Vayro, S., Zablocka, B., and Górecki, D. C. (2010). Changes in the expression of insulin-like growth factor 1 variants in the postnatal brain development and in neonatal hypoxia-ischaemia. Int. J. Dev. Neurosci. 28, 91-97.
9. Bichell, D., Kikuchi, K., and Rotwein, P. (1992). Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol. Endocrinol. 6, 1899- 1908.
10. Bonapace, G., Concolino, D., Formicola, S., and Strisciuglio, P. (2003). A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J. Med. Genet. 40, 913-917.
11. Brennan, C., and Steitz, J. (2001). HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266-277.
12. Butler, A., Ambler, G., Breier, B., Leroith, D., Roberts, C., and Gluckman, P. (1994). Growth hormone (GH) and insulin-like growth factor-I (IGF-I) treatment of the GH-deficient dwarf rat: differential effects on IGF-I transcription start site expression in hepatic and extrahepatic tissues and lack of effect on type I IGF receptor mRNA expression. Mol. Cell. Endocrinol. 101, 321-330.
13. Cacciatore, I., Cornacchia, C., Baldassarre, L., Fornasari, E., Mollica, A., Stefanucci, A., et al. (2012). GPE and GPE analogues as promising neuroprotective agents. Mini Rev. Med. Chem. 12, 13-23.
14. Chew, S., Lavender, P., Clark, A., and Ross, R. (1995). An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology 136, 1939-1944.
15. Chia, D. J., Ono, M., Woelfle, J., Schlesinger-Massart, M., Jiang, H., and Rotwein, P. (2006). Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription. J. Biol. Chem. 281, 3190-3197.
16. Coleman, M. E., Demayo, F., Yin, K. C., Lee, H. M., Geske, R., Montgomery, C., et al. (1995). Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270, 12109-12116.
17. Coutinho, D. C., Coletta, R. R. D., Costa, E. M. F., Pachi, P. R., Boguszewski, M. C. S., Damiani, D., et al. (2007). Polymorphisms identified in the upstream core polyadenylation signal of IGF1 gene exon 6 do not cause pre-and postnatal growth impairment. J. Clin. Endocrinol. Metab. 92, 4889-4892.
18. Croci, L., Barili, V., Chia, D., Massimino, L., Van Vugt, R., Masserdotti, G., et al. (2010). Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth. Cell Death Differ. 18, 48-59.
19. Dai, Z., Wu, F., Yeung, E. W., and Li, Y. (2010). IGF-IEc expression, regulation and biological function in different tissues. Growth Horm. IGF Res. 20, 275-281.
20. Duguay, S. J., Lai-Zhang, J., and Steiner, D. F. (1995). Mutational analysis of the insulin-like growth factor I prohormone processing site. J. Biol. Chem. 270, 17566- 17574.
21. Foyt, H., Lanau, F., Woloschak, M., Leroith, D., and Roberts, C. (1992). Effect of growth hormone on levels of differentially processed insulin-like growth factor I mRNAs in total and polysomal mRNA populations. Mol. Endocrinol. 6, 1881-1888.
22. Foyt, H., Leroith, D., and Roberts, C. Jr. (1991). Differential association of insulin-like growth factor I mRNA variants with polysomes in vivo. J. Biol. Chem. 266, 7300-7305.
23. Fu, Q., Yu, X., Callaway, C. W., Lane, R. H., and McKnight, R. A. (2009). Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J. 23, 2438-2449.
24. Fuqua, J. S., Derr, M., Rosenfeld, R. G., and Hwa, V. (2012). Identification of a novel heterozygous IGF1 splicing mutation in a large kindred with familial short stature. Horm. Res. Paediatr. 78, 59-66.
25. Gauguin, L., Delaine, C., Alvino, C. L., McNeil, K. A., Wallace, J. C., Forbes, B. E., et al. (2008). Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. J. Biol. Chem. 283, 20821-20829.
26. Gentile, M. A., Nantermet, P. V., Vogel, R. L., Phillips, R., Holder, D., Hodor, P., et al. (2010). Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of β-catenin. J. Mol. Endocrinol. 44, 55-73.
27. Gilmour, R. (1994). The implications of insulin-like growth factor mRNA heterogeneity. J. Endocrinol. 140, 1-3.
28. Goldspink, G., and Yang, S. Y. (2004). The splicing of the IGF-I gene to yield different muscle growth factors. Adv. Genet. 52, 23-49.
29. Gruber, A. R., Fallmann, J., Kratochvill, F., Kovarik, P., and Hofacker, I. L. (2011). AREsite: a database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res. 39, D66-D69.
30. Haddad, F., and Adams, G. R. (2002). Selected contribution: acute cellular and molecular responses to resistance exercise. J. Appl. Physiol. 93, 394-403.
31. Hameed, M., Lange, K., Andersen, J., Schjerling, P., Kjaer, M., Harridge, S., et al. (2004a). The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J. Physiol. (Lond.) 555, 231-240.
32. Hameed, M., Orrell, R., Cobbold, M., Goldspink, G., and Harridge, S. (2004b). Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J. Physiol. (Lond.) 547, 247-254.
33. Hede, M. S., Salimova, E., Piszczek, A., Perlas, E., Winn, N., Nastasi, T., et al. (2012). E-peptides control bioavailability of IGF-1. PLoS ONE 7, e51152. doi:10.1371/journal.pone.0051152
34. Hepler, J. E., Van Wyk, J. J., and Lund, P. K. (1990). Different half-lives of insulin-like growth factor I mRNAs that differ in length of 3βuntranslated sequence. Endocrinology 127, 1550-1552.
35. Hewitt, S. C., Li, Y., Li, L., and Korach, K. S. (2010). Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor β. to estrogen-responsive elements. J. Biol. Chem. 285, 2676-2685.
36. Hill, M., and Goldspink, G. (2004). Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J. Physiol. (Lond.) 549, 409-418.
37. Holthuizen, E., Leroith, D., Lund, P., Roberts, C., Rotwein, P., Spencer, E., et al. (1991). "Revised nomenclature for the insulin-like growth factor 689 genes and transcripts," in Modern Concepts of Insulin-Like Growth Factors, ed. E. M. Spencer (New York: Elsevier Science), 733-736.
38. Imanaka, M., Iida, K., Murawaki, A., Nishizawa, H., Fukuoka, H., Takeno, R., et al. (2008). Growth hormone stimulates mechano growth factor expression and activates myoblast transformation in C2C12 cells. Kobe J. Med. Sci. 54, E46-54.
39. Inukai, S., and Slack, F. (2013). MicroRNAs and the genetic network in aging. J. Mol. Biol. doi:10.1016/j.jmb.2013.01.023
40. Jansen, E., Steenbergh, P., Van Schaik, F., and Sussenbach, J. (1992). The human IGF-I gene contains two cell type-specifically regulated promoters. Biochem. Biophys. Res. Commun. 187, 1219-1226.
41. Jansen, M., Van Schaik, F., Ricker, A., Bullock, B., Woods, D., Gabbay, K., et al. (1983). Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature 306, 609-611.
42. Katsanou, V., Papadaki, O., Milatos, S., Blackshear, P. J., Anderson, P., Kollias, G., et al. (2005). HuR as a negative posttranscriptional modulator in inflammation. Mol. Cell 19, 777-789.
43. Kawai, M., Delany, A. M., Green, C. B., Adamo, M. L., and Rosen, C. J. (2010). Nocturnin suppresses igf1 expression in bone by targeting the 3β. untranslated region of igf1 mRNA. Endocrinology 151, 4861-4870.
44. Kwiecinski, M., Elfimova, N., Noetel, A., Töx, U., Steffen, H. M., Hacker, U., et al. (2012). Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Lab. Invest. 92, 978-987.
45. Laugero, L., and Oberbauer, A. (2000). Stability of alternatively spliced IGF-I mRNA in growth plate chondrocytes. Connect. Tissue Res. 41, 165-174.
46. Lee, E. K., and Gorospe, M. (2010). Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systems. Endocrinology 151, 1403-1408.
47. LeRoith, D., and Roberts, C. (1991). Insulin-like growth factor I (IGF-I): a molecular for endocrine versus local action?. Mol. Cell. Endocrinol. 77, C57-C61.
48. Li, J., Owens, J. A., Owens, P. C., Saunders, J., Fowden, A. L., and Gilmour, R. (1996). The ontogeny of hepatic growth hormone receptor and insulin-like growth factor I gene expression in the sheep fetus during late gestation: developmental regulation by cortisol. Endocrinology 137, 1650-1657.
49. Liang, R., and Wang, E. (2012). Full-length 3β-untranslated region reporter construction with recombineering. Anal. Biochem. 424, 162-167.
50. Lin, W., and Oberbauer, A. (1998). Alternative splicing of insulin-like growth factor I mRNA is developmentally regulated in the rat and mouse with preferential exon 2 usage in the mouse. Growth Horm. IGF Res. 8, 225-233.
51. Lin, W., and Oberbauer, A. (1999). Spatiotemporal expression of alternatively spliced IGF-I mRNA in the rat costochondral growth plate. J. Endocrinol. 160, 461- 467.
52. Lin, W. W., Murray, J., and Oberbauer, A. (1998). Overexpression of growth hormone affects alternatively spliced IGF-I mRNA expression in oMt1a-oGH transgenic mice. Transgenic Res. 7, 295-302.
53. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993). Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72.
54. Lowe, W. L., Roberts, C. T., Lasky, S. R., and Leroith, D. (1987). Differential expression of alternative 5βuntranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc. Natl. Acad. Sci. U.S.A. 84, 8946-8950.
55. Lowe, W. L., and Teasdale, R. M. (1992). Characterization of a rat insulin-like growth factor I gene promoter. Biochem. Biophys. Res. Commun. 189, 972-978.
56. Lund, P. K., Hoyt, E. C., and Van Wyk, J. J. (1989). The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of 3β. -untranslated sequence. Mol. Endocrinol. 3, 2054-2061.
57. Magee, B. A., Shooter, G. K., Wallace, J. C., and Francis, G. L. (1999). Insulin-like growth factor I and its binding proteins: a study of the binding interface using Bdomain analogues. Biochemistry 38, 15863-15870.
58. Matheny, R. W., Nindl, B. C., and Adamo, M. L. (2010). Minireview: mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 151, 865-875.
59. Mathews, L. S., Norstedt, G., and Palmiter, R. D. (1986). Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl. Acad. Sci. U.S.A. 83, 9343-9347.
60. McLellan, A. S., Kealey, T., and Langlands, K. (2006). An E box in the exon 1 promoter regulates insulin-like growth factor-I expression in differentiating muscle cells. Am. J. Physiol. Cell Physiol. 291, C300-C307.
61. Myer, V. E., Fan, X. C., and Steitz, J. A. (1997). Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16, 2130-2139.
62. Nolten, L., Van Schaik, F., Steenbergh, P., and Sussenbach, J. (1994). Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBP alpha and LAP. Mol. Endocrinol. 8, 1636-1645.
63. Nolten, L. A., Steenbergh, P. H., and Sussenbach, J. S. (1996). The hepatocyte nuclear factor 3β. stimulates the transcription of the human insulin-like growth factor I gene in a direct and indirect manner. J. Biol. Chem. 271, 31846-31854.
64. Ohtsuki, T., Otsuki, M., Murakami, Y., Hirata, K., Takeuchi, S., and Takahashi, S. (2007). Alternative leader-exon usage in mouse IGF-I mRNA variants: class 1 and class 2 IGF-I mRNAs. Zool. Sci. 24, 241-247.
65. O'Sullivan, D., Szestak, T., and Pell, J. (2002a). Regulation of hepatic insulin-like growth factor I leader exon usage in lambs: effect of immunization against growth hormone-releasing factor and subsequent growth hormone treatment. J. Anim. Sci. 80, 1074-1082.
66. O'Sullivan, D., Szestak, T., and Pell, J. (2002b). Regulation of IGF-I mRNA by GH: putative functions for class 1 and 2 message. Am. J. Physiol. Endocrinol. Metab. 283, E251-E258.
67. Owino, V., Yang, S. Y., and Goldspink, G. (2001). Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett. 505, 259-263.
68. Philippou, A., Maridaki, M., Halapas, A., and Koutsilieris, M. (2007). The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In vivo 21, 45 -54.
69. Pöllänen, E., Ronkainen, P. H., Horttanainen, M., Takala, T., Puolakka, J., Suominen, H., et al. (2010). Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle. Growth Horm. IGF Res. 20, 372-379.
70. Pursel, V., Mitchell, A., Bee, G., Elsasser, T., McMurtry, J., Wall, R., et al. (2004). Growth and tissue accretion rates of swine expressing an insulin-like growth factor I transgene. Anim. Biotechnol. 15, 33-45.
71. Roberts, C. T., Lasky, S. R., Lowe, W. L., Seaman, W. T., and Leroith, D. (1987). Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol. Endocrinol. 1, 243-248.
72. Rotwein, P. (2012). Mapping the growth hormone-Stat5b-IGF-I transcriptional circuit. Trends Endocrinol. Metab. 23, 186-193.
73. Rotwein, P., Pollock, K., Didier, D., and Krivi, G. (1986). Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J. Biol. Chem. 261, 4828-4832.
74. Sara, V. R., Carlsson-Skwirut, C., Bergman, T., Jörnvall, H., Roberts, P. J., Crawford, M., et al. (1989). Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide. Biochem. Biophys. Res. Commun. 165, 766-771.
75. Sara, V. R., Carlsson-Skwirut, C., Drakenberg, K., Giacobini, M., åkansson, L., Mirmiran, M., et al. (1993). The biological role of truncated insulin-like growth factor -1 and the tripeptide GPE in the central nervous system. Ann. N. Y. Acad. Sci. 692, 183-191.
76. Sasaki, H., Hayakawa, J., Terai, Y., Kanemura, M., Tanabe-Kimura, A., Kamegai, H., et al. (2008). Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines. Oncogene 27, 2737-2745.
77. Schober, M. E., Ke, X., Xing, B., Block, B. P., Requena, D. F., McKnight, R., et al. (2012). Traumatic brain injury increased IGF-1B mRNA and altered IGF-1 exon 5 and promoter region epigenetic characteristics in the rat pup hippocampus. J. Neurotrauma 29, 2075-2085.
78. Schwander, J., Hauri, C., Zapf, J., and Froesch, E. (1983). Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113, 297-305.
79. Shavlakadze, T., Winn, N., Rosenthal, N., and Grounds, M. D. (2005). Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm. IGF Res. 15, 4-18.
80. Shemer, J., Adamo, M., Roberts, C. Jr., and Leroith, D. (1992). Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. Endocrinology 131, 2793-2799.
81. Shimatsu, A., and Rotwein, P. (1987). Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene. J. Biol. Chem. 262, 7894-7900.
82. Shoba, L., An, M. R., Frank, S. J., and Lowe, W. L. (1999). Developmental regulation of insulin-like growth factor-I and growth hormone receptor gene expression. Mol. Cell. Endocrinol. 152, 125-136.
83. Simmen, F. (1991). Expression of the insulin-like growth factor-I gene and its products: complex regulation by tissue specific and hormonal factors. Domest. Anim. Endocrinol. 8, 165-178.
84. Simmons, J. G., Van Wyk, J. J., Hoyt, E. C., and Lund, P. K. (1993). Multiple transcription start sites in the rat insulin-like growth factor-I gene give rise to IGF-I mRNAs that encode different IGF-I precursors and are processed differently in vitro. Growth Factors 9, 205-221.
85. Sjögren, K., Liu, J. L., Blad, K., Skrtic, S., Vidal, O., Wallenius, V., et al. (1999). Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. U.S.A. 96, 7088-7092.
86. Smith, P. J., Spurrell, E. L., Coakley, J., Hinds, C. J., Ross, R. J. M., Krainer, A. R., et al. (2002). An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor. Endocrinology 143, 146-154.
87. Sussenbach, J., Steenbergh, P., and Holthuizen, P. (1992). Structure and expression of the human insulin-like growth factor genes. Growth Regul. 2, 1.
88. Tan, D. S. W., Cook, A., and Chew, S. L. (2002). Nucleolar localization of an isoform of the IGF-I precursor. BMC Cell Biol. 3, 17. doi:10.1186/1471-2121-3-17
89. Tang, L. L., Xian, C. Y., and Wang, Y. L. (2006). The MGF expression of osteoblasts in response to mechanical overload. Arch. Oral Biol. 51, 1080-1085.
90. Telgmann, R., Dördelmann, C., Brand, E., Nicaud, V., Hagedorn, C., Pavenstädt, H., et al. (2009). Molecular genetic analysis of a human insulin-like growth factor 1 promoter P1 variation. FASEB J. 23, 1303-1313.
91. Temmerman, L., Slonimsky, E., and Rosenthal, N. (2010). Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels. Growth Horm. IGF Res. 20, 255-263.
92. Thomas, M., Kikuchi, K., Bichell, D., and Rotwein, P. (1995). Characterization of deoxyribonucleic acid-protein interactions at a growth hormone-inducible nuclease hypersensitive site in the rat insulin-like growth factor-I gene. Endocrinology 136, 562-569.
93. Varco-Merth, B., Mirza, K., Alzhanov, D. T., Chia, D. J., and Rotwein, P. (2012). Biochemical characterization of diverse Stat5b-binding enhancers that mediate growth hormone-activated insulin-like growth factor-I gene transcription. PLoS ONE 7, e50278. doi:10.1371/journal.pone.0050278
94. Wang, L., Wang, X., and Adamo, M. L. (2000). Two putative GATA motifs in the proximal exon 1 promoter of the rat insulin-like growth factor I gene regulate basal promoter activity. Endocrinology 141, 1118-1126.
95. Wang, X., Yang, Y., and Adamo, M. L. (1997). Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoter. Endocrinology 138, 1528-1536.
96. Wang, Y., Price, S., and Jiang, H. (2003). Cloning and characterization of the bovine class 1 and class 2 insulin-like growth factor-I mRNAs. Domest. Anim. Endocrinol. 25, 315-328.
97. Weber, J. D., Kuo, M. L., Bothner, B., Digiammarino, E. L., Kriwacki, R. W., Roussel, M. F., et al. (2000). Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20, 2517-2528.
98. Winter, J., Jung, S., Keller, S., Gregory, R. I., and Diederichs, S. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228-234.
99. Woelfle, J., Billiard, J., and Rotwein, P. (2003a). Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J. Biol. Chem. 278, 22696-22702.
100. Woelfle, J., Chia, D. J., and Rotwein, P. (2003b). Mechanisms of growth hormone (GH) action. J. Biol. Chem. 278, 51261-51266.
101. Xie, X., Lu, J., Kulbokas, E., Golub, T. R., Mootha, V., Lindblad-Toh, K., et al. (2005). Systematic discovery of regulatory motifs in human promoters and 3β. UTRs by comparison of several mammals. Nature 434, 338-345.
102. Yan, B., Zhao, L., Guo, J., and Zhao, J. (2013). miR-206 regulates the growth of the teleost tilapia (Oreochromis niloticus) through the modulation of IGF-1 gene expression. J. Exp. Biol. 216, 1265-1269.
103. Yang, H., Adamo, M. L., Koval, A. P., McGuinness, M. C., Ben-Hur, H., Yang, Y., et al. (1995). Alternative leader sequences in insulin-like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides. Mol. Endocrinol. 9, 1380-1395.
104. Yang, S., Alnaqeeb, M., Simpson, H., and Goldspink, G. (1996). Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J. Muscle Res. Cell. Motil. 17, 487-495.